MegaMD Co (133750) Fair Value & Analysis
Consumer Defensive · KR · Market cap 29.2B KRW
Fair value as of: Jul 22, 2026
From 22 valuation models · updated 19 days ago
Share price +9.0% over the past month.
A solid business, screening 50% undervalued on our models.
What matters now
- The price is below even our cautious bear case (1,715 KRW). The market is more pessimistic than our downside scenario.
- Solid quality (64/100) at a price below fair value, the discount is the argument here, not the business quality.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 22, 2026.
How to read this chart
60‑month range 1,302 KRW – 6,214 KRW · fair‑value band 1,715 KRW – 2,686 KRW · the 1,429 KRW price screens below the 2,149 KRW fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 22, 2026.
Analysis
MegaMD Co (133750) currently trades at 1,429 KRW, while our model-based Fair Value estimate is 2,149 KRW, implying the stock looks roughly 50.4% undervalued today. The Quality Score stands at 64/100 (solid quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.
Over the trailing twelve months, MegaMD Co generated revenue of 35.2B KRW at a net margin of 8.9%. Revenue declined 9.0% year over year. It earns a return on equity of 4.8%. Fundamentals as of Jul 22, 2026
Our scenario range runs from 1,715 KRW (bear case) to 2,686 KRW (bull case); at 1,429 KRW, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 33% below its 52-week high and 5% above its 52-week low, currently below its 200-day average. For context, the median of 10 Consumer Defensive peers we cover trades at 17% fair-value upside, at 50%, 133750 screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 22 models by family
Widest divergence: DCF Models (2,870 KRW) versus Earnings-Based (1,050 KRW). Highest evidence: Growth DCF (80).
Notify me when 133750 reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 22, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 62 · Market factors (momentum, volatility) 34
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
MegaMD Co., Ltd. engages in the operation of educational institutions in South Korea. The company's education services specialize in infant, elementary, middle, and high school education, as well as adult entrance exams. It is also involved in the operation of online lecture sites; and provision of information services.
Full company description
MegaMD Co., Ltd. engages in the operation of educational institutions in South Korea. The company's education services specialize in infant, elementary, middle, and high school education, as well as adult entrance exams. It is also involved in the operation of online lecture sites; and provision of information services. The company was founded in 2004 and is headquartered in Seoul, South Korea.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
MegaMD Co reported revenue of 34.6B KRW in FY2025 versus 79.4B KRW in FY2021, a compound −18.8%/yr. Reported net income was 2.8B KRW in FY2025, compounding −19.5%/yr from FY2021.
Watch 133750: get an alert when its fair value changes →
Peer Group
Education & Training Services · 148 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Education & Training Services median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Education & Training Services stocks, each showing price versus our Fair Value estimate (as of Jul 22, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| New Oriental Education & Technology Group EDUN | 966.48 MXN | 897.37 MXN | -7% |
| TAL Education Group TAL | $10.24 | $15.60 | +52% |
| Laureate Education, Inc LAUR | $36.45 | $41.45 | +14% |
| Physicswallah Limited PWL | ₹131.59 | ₹14.81 | -89% |
| Grand Canyon Education, Inc LOPE | $149.00 | $152.01 | +2% |
| Covista Inc CVSA | $116.22 | $135.45 | +17% |
| Stride, Inc LRN | $83.39 | $139.45 | +67% |
| Universal Technical Institute, Inc UTI | $40.33 | $21.35 | -47% |
| Perdoceo Education Corporation PRDO | $31.66 | $41.45 | +31% |
| Strategic Education, Inc STRA | $84.18 | $105.48 | +25% |
Compare MegaMD Co with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Consumer Defensive stocks →
Frequently asked questions
Is MegaMD Co (133750) overvalued or undervalued?
What is the fair value of 133750?
What is the quality score of 133750?
What is the revenue of MegaMD Co (133750)?
What is the net profit margin of 133750?
Does MegaMD Co pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track MegaMD Co and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.